— Know what they know.
Not Investment Advice

EMGE OTC

Emergent Health Corp
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: -0.0% 1Y: +0.0% 3Y: -88.2% 5Y: -99.8%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 47 · $4193 mcap · Short 84% of daily vol

Income Trends

Revenue
$2M +184.5% ▲
5Y CAGR: +10.6%
Gross Profit
$1M +713.4% ▲
5Y CAGR: +7.3%
Operating Income
-$1M +19.8% ▲
Net Income
-$2M +22.7% ▲
EPS (Diluted)
$-0.00 +50.6% ▲
EBITDA
-$1M +19.7% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2019FY2020FY2021FY2022FY2023
Revenue$183K$167K$120K$575K$2M
YoY Growth+0.0%-8.7%-28.5%+380.6%+184.5%
Cost of Revenue$54K$46K$60K$447K$597K
Gross Profit$129K$121K$59K$128K$1M
Gross Margin70.3%72.6%49.7%22.2%63.5%
R&D Expenses$10K$2K$2K$9K$28K
SG&A Expenses$178K$176K$257K$2M$2M
Operating Expenses$187K$201K$259K$2M$2M
Operating Income-$59K-$80K-$200K-$2M-$1M
Operating Margin-32.1%-47.7%-166.9%-305.6%-86.1%
Interest Expense$10K$0$90K$362K$220K
Income Before Tax-$69K-$80K-$290K-$2M-$2M
Tax Expense$0$0$0$0$0
Net Income-$67K-$79K-$289K-$2M-$2M
Net Margin-36.9%-47.3%-241.5%-366.8%-99.6%
EPS (Diluted)$-0.00$-0.00$-0.01$-0.01$-0.00
EBITDA-$49K-$56K-$180K-$2M-$1M
Shares Outstanding56M57M58M261M403M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms